Hanson McClain Advisors »

Larimar Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2k 359 3.23
2023-03-31 $59 13 4.54

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Blue Owl Capital Holdings
Millennium Management
Opaleye Management
BlackRock
Rtw Investments
Vanguard Group
Caption Management
Logos Global Management
Adage Capital Partners GP
Alyeska Investment Group
Citadel Advisors
Woodline Partners
Goldman Sachs Group

View all funds holding Larimar Therapeutics